Oxurion NV (GB:0G99) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion, resulting in a capital increase of EUR 100,000, as part of a larger EUR 20 million capital commitment. This financial move supports Oxurion’s efforts in developing innovative ophthalmological drugs targeting a market worth USD 3-6 billion. Following the conversion, Oxurion’s total shares amount to 13,362,647,372 with corresponding voting rights.
For further insights into GB:0G99 stock, check out TipRanks’ Stock Analysis page.
